The Digital Mammographic Imaging Screening Trial (DMIST) is a multi-institutional research study, beginning in 2001, on the efficacy for screening of full-field digital mammography (FFDM) compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by the American College of Radiology Imaging Network (ACRIN).[1]
The findings[2][3] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.[citation needed] On the other hand, women with dense breasts receive two to three times the amount of radiation during their imaging as dense breasts absorb more X-ray because of the density (difficulty of the X-ray to penetrate dense tissue).[citation needed]
Referencesedit
^Galen, Barbara; Staab, Edward; Sullivan, Daniel C.; Pisano, Etta D. "American College of Radiology Imaging Network: The Digital Mammographic Imaging Screening Trial—An Update" (PDF). National Cancer Institute. Retrieved 13 December 2023.
^Pisano, Etta (27 October 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". New England Journal of Medicine. NEJM. 353 (17): 1773–1783. doi:10.1056/NEJMoa052911. PMID 16169887. Retrieved 11 February 2010.
^Dershaw, D. David (27 October 2005). "Film or Digital Mammographic Screening?". The New England Journal of Medicine. 353 (17): 1846–1847. doi:10.1056/NEJMe058253. PMID 16251541. Retrieved 11 February 2010.
External linksedit
ACRIN-6652
December 15, 2023
digital, mammographic, imaging, screening, trial, dmist, multi, institutional, research, study, beginning, 2001, efficacy, screening, full, field, digital, mammography, ffdm, compared, conventional, film, screen, mammography, that, sponsored, national, cancer,. The Digital Mammographic Imaging Screening Trial DMIST is a multi institutional research study beginning in 2001 on the efficacy for screening of full field digital mammography FFDM compared to conventional film screen mammography that was sponsored by the U S National Cancer Institute and performed by the American College of Radiology Imaging Network ACRIN 1 The findings 2 3 that FFDM was not inferior to the existing technology and potentially superior in younger women with dense breasts has led to a rapid proliferation of digital systems in the US citation needed On the other hand women with dense breasts receive two to three times the amount of radiation during their imaging as dense breasts absorb more X ray because of the density difficulty of the X ray to penetrate dense tissue citation needed References edit Galen Barbara Staab Edward Sullivan Daniel C Pisano Etta D American College of Radiology Imaging Network The Digital Mammographic Imaging Screening Trial An Update PDF National Cancer Institute Retrieved 13 December 2023 Pisano Etta 27 October 2005 Diagnostic Performance of Digital versus Film Mammography for Breast Cancer Screening New England Journal of Medicine NEJM 353 17 1773 1783 doi 10 1056 NEJMoa052911 PMID 16169887 Retrieved 11 February 2010 Dershaw D David 27 October 2005 Film or Digital Mammographic Screening The New England Journal of Medicine 353 17 1846 1847 doi 10 1056 NEJMe058253 PMID 16251541 Retrieved 11 February 2010 External links editACRIN 6652 Retrieved from https en wikipedia org w index php title Digital Mammographic Imaging Screening Trial amp oldid 1189753812, wikipedia, wiki, book, books, library,
